These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 8782131

  • 1. Methotrexate in nonrenal lupus and undifferentiated connective tissue disease--a review of 36 patients.
    Wise CM, Vuyyuru S, Roberts WN.
    J Rheumatol; 1996 Jun; 23(6):1005-10. PubMed ID: 8782131
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus.
    Ravelli A, Ballardini G, Viola S, Villa I, Ruperto N, Martini A.
    J Rheumatol; 1998 Mar; 25(3):572-5. PubMed ID: 9517783
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis.
    Rahman P, Humphrey-Murto S, Gladman DD, Urowitz MB.
    J Rheumatol; 1998 Feb; 25(2):243-6. PubMed ID: 9489814
    [Abstract] [Full Text] [Related]

  • 4. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
    Carneiro JR, Sato EI.
    J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
    [Abstract] [Full Text] [Related]

  • 5. Methotrexate in systemic lupus erythematosus.
    Walz LeBlanc BA, Dagenais P, Urowitz MB, Gladman DD.
    J Rheumatol; 1994 May; 21(5):836-8. PubMed ID: 8064722
    [Abstract] [Full Text] [Related]

  • 6. A 2 year, open ended trial of methotrexate in systemic lupus erythematosus.
    Wilson K, Abeles M.
    J Rheumatol; 1994 Sep; 21(9):1674-7. PubMed ID: 7799348
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of methotrexate in articular and cutaneous manifestations of systemic lupus erythematosus.
    Islam MN, Hossain M, Haq SA, Alam MN, Ten Klooster PM, Rasker JJ.
    Int J Rheum Dis; 2012 Feb; 15(1):62-8. PubMed ID: 22324948
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
    Wenzel J, Brähler S, Bauer R, Bieber T, Tüting T.
    Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
    [Abstract] [Full Text] [Related]

  • 9. Methotrexate therapy in connective tissue diseases: a review of the literature.
    Jeurissen ME, Boerbooms AM, van de Putte LB.
    Neth J Med; 1989 Aug; 35(1-2):44-58. PubMed ID: 2674740
    [Abstract] [Full Text] [Related]

  • 10. Methotrexate therapy in childhood systemic lupus erythematosus.
    Abud-Mendoza C, Sturbaum AK, Vazquez-Compean R, Gonzalez-Amaro R.
    J Rheumatol; 1993 Apr; 20(4):731-3. PubMed ID: 8496874
    [Abstract] [Full Text] [Related]

  • 11. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease.
    Fautrel B, Borget C, Rozenberg S, Meyer O, Le Loët X, Masson C, Koeger AC, Kahn MF, Bourgeois P.
    J Rheumatol; 1999 Feb; 26(2):373-8. PubMed ID: 9972972
    [Abstract] [Full Text] [Related]

  • 12. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
    van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ, Etanercept Study 400 Investigators.
    Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
    Gubar' EE, Bochkova AG, Bunchuk NV.
    Ter Arkh; 2008 Feb; 80(5):25-30. PubMed ID: 18590110
    [Abstract] [Full Text] [Related]

  • 14. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
    Weatherhead SC, Wahie S, Reynolds NJ, Meggitt SJ.
    Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
    Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, Antoni C, Leeb B, Elliott MJ, Woody JN, Schaible TF, Feldmann M.
    Arthritis Rheum; 1998 Sep; 41(9):1552-63. PubMed ID: 9751087
    [Abstract] [Full Text] [Related]

  • 16. Intrathecal injection with methotrexate plus dexamethasone in the treatment of central nervous system involvement in systemic lupus erythematosus.
    Dong Y, Zhang X, Tang F, Tian X, Zhao Y, Zhang F.
    Chin Med J (Engl); 2001 Jul; 114(7):764-6. PubMed ID: 11780346
    [Abstract] [Full Text] [Related]

  • 17. Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
    Fortin PR, Abrahamowicz M, Ferland D, Lacaille D, Smith CD, Zummer M, Canadian Network For Improved Outcomes in Systemic Lupus.
    Arthritis Rheum; 2008 Dec 15; 59(12):1796-804. PubMed ID: 19035431
    [Abstract] [Full Text] [Related]

  • 18. [Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy].
    Bodolay E, Szegedi G.
    Orv Hetil; 2002 Feb 03; 143(5):229-33. PubMed ID: 11875835
    [Abstract] [Full Text] [Related]

  • 19. Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial.
    Fleischmann RM, Cohen SB, Moreland LW, Schiff M, Mease PJ, Smith DB, Keenan G, Kremer JM, iRAMT Study Group.
    Curr Med Res Opin; 2005 Aug 03; 21(8):1181-90. PubMed ID: 16083527
    [Abstract] [Full Text] [Related]

  • 20. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V.
    Arthritis Rheum; 2004 Feb 03; 50(2):364-71. PubMed ID: 14872477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.